SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493526-12-000013
Filing Date
2012-09-07
Accepted
2012-09-06 17:48:19
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 dec1110kaprotectvedgarkmev2.htm 10-K/A 832975
2 exhibit311.htm EX-31 5665
3 exhibit312.htm EX-31 5702
4 exhibit321.htm EX-32 4087
5 exhibit322.htm EX-32 4333
  Complete submission text file 0001493526-12-000013.txt   1417421

Data Files

Seq Description Document Type Size
6 prtt-20111231.xml EX-101.INS 55915
7 prtt-20111231.xsd EX-101.SCH 4958
8 prtt-20111231_cal.xml EX-101.CAL 2144
9 prtt-20111231_def.xml EX-101.DEF 40551
10 prtt-20111231_lab.xml EX-101.LAB 62226
11 prtt-20111231_pre.xml EX-101.PRE 45661
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

IRS No.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-54001 | Film No.: 121077803
SIC: 2834 Pharmaceutical Preparations